FundingWatcher
Home / Startups / Top biotech startups / Biotech startups in South San Francisco, California

Biotech startups in South San Francisco, California

Updated 16 Nov 2026

Reset
Biotech startups in South San Francisco, California
One-time CSV
  • 69 funded companies, 62 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech~south-san-francisco-california.csv69 rows × 18 columns
CompanyCityLast roundAmountDate
Moonwalk BiosciencesSouth San FranciscoSeries B$70.0M2026-09-08
Xaira TherapeuticsSouth San FranciscoSeries A$1.0B2024-04-23
Lycia TherapeuticsSouth San FranciscoSeries D$75.0M2026-06-25
InsitroSouth San FranciscoSeries C$400.0M2021-03-15
Circle PharmaSouth San FranciscoSeries E$92.5M2026-09-16
InterVennSouth San FranciscoSeries C$201.0M2021-08-02
ArsenalBioSouth San FranciscoSeries C$325.0M2024-09-04
Shinobi TherapeuticsSouth San FranciscoSeries A$68.0M2024-08-06

8 rows of the CSV in 5 of its 18 columns.

69
Startups
$9.9B
Total raised
14
Funded in the last 12 months
$1.5B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

13 of 69
13 rows
Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech Series E $92.5M 2026-09-16 $300.0M Mission BioCapital, Pfizer, The Column Group +1 11 to 50 2012
Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022
Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
Trace Neuroscience Trace Neuroscience aims to extend the promise of genetic medicine to patients. Biotech Series A $101.0M 2024-11-12 $101.0M RA Capital Management, Atlas Venture, Third Rock Ventures 11 to 50 2024
ArsenalBio ArsenalBio develops programmable CAR T-cell therapies for solid tumors. Biotech Series C $325.0M 2024-09-04 $630.8M ARCH Venture Partners, Bristol-Myers Squibb, NVentures +1 251 to 500 2019
Shinobi Therapeutics Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment. Biotech Series A $68.0M 2024-08-06 $178.0M Mitsubishi UFJ Capital, F-Prime, EQT Life Sciences +2 11 to 50 2023
NGM Biopharmaceuticals NGM Biopharmaceuticals discovers and develops biotherapeutics for gastrointestinal and endocrine disorders. Biotech Series A $122.0M 2024-07-17 $542.4M Rho Capital Partners, Greenspring Associates, The Column Group 11 to 50 2008
Xaira Therapeutics Unicorn Xaira Therapeutics applies artificial intelligence to drug discovery and biotechnology research. Artificial intelligence Series A $1.0B 2024-04-23 $1.0B Sequoia Capital, New Enterprise Associates, Menlo Ventures +2 101 to 250 2023
Velorum Therapeutics Velorum Therapeutics develops cancer treatments that starve tumors of their blood supply. Biotech Pre-seed $500K 2024-02-27 $500K Y Combinator, Eight Capital 1 to 10 2023
HI-Bio HI-Bio develops therapies for immune-mediated diseases. Biotech Series B $95.0M 2024-01-04 $215.0M ARCH Venture Partners, Alpha Wave Global, Viking Global Investors +1 101 to 250 2021
InterVenn InterVenn uses artificial intelligence to study the glycoproteome for diagnostic and therapeutic healthcare solutions. Artificial intelligence Series C $201.0M 2021-08-02 $244.4M True Ventures, Boost VC, Anzu Partners +2 51 to 100 2017
Insitro Unicorn Insitro applies machine learning and biology to drug discovery and development. Artificial intelligence Series C $400.0M 2021-03-15 $643.0M Temasek, BlackRock, ARCH Venture Partners +1 251 to 500 2018
Solstice Neurosciences Solstice Neurosciences develops, manufactures, sells, and markets specialty biopharmaceutical products. Biotech Series B $85.0M 2006-11-08 $93.0M Highland Capital Partners, Investor Growth Capital Limited, Morgan Stanley Venture Partners +2 51 to 100 2003

Table 1. Biotech startups in South San Francisco, California: the 13 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 69.

Largest rounds

Last 12 months
# Company What they do Sector Last round Amount Date Total raised Investors Employees Founded
1 Circle Pharma Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. Biotech Series E $92.5M 2026-09-16 $300.0M Mission BioCapital, Pfizer, The Column Group +1 11 to 50 2012
2 Lycia Therapeutics Lycia Therapeutics develops technology using lysosome-targeting chimeras to degrade disease-causing proteins. Biotech Series D $75.0M 2026-06-25 $301.6M Franklin Templeton, Alexandria Venture Investments, Invus +1 11 to 50 2019
3 Moonwalk Biosciences Moonwalk Biosciences develops precision epigenetic medications through its genomic medicine platform. Artificial intelligence Series B $70.0M 2026-09-08 $127.0M Google Ventures, Khosla Ventures, ARCH Venture Partners +2 11 to 50 2022

Table 2. Biotech startups in South San Francisco, California: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 ARCH Venture Partners Venture capital firm Chicago, United States 5 7% 1 Moonwalk Biosciences
2 Alpha Wave Global Private equity firm Miami, United States 2 3% 1 Moonwalk Biosciences
3 F-Prime Venture capital firm Cambridge, United States 2 3%
4 Alexandria Venture Investments Venture capital firm Pasadena, United States 2 3% 1 Lycia Therapeutics
5 The Column Group Venture capital firm San Francisco, United States 2 3% 1 Circle Pharma
6 Future Ventures Venture capital firm San Francisco, United States 1 1% 1 Moonwalk Biosciences
7 Google Ventures Corporate venture arm San Francisco, United States 1 1% 1 Moonwalk Biosciences
8 Khosla Ventures Venture capital firm Menlo Park, United States 1 1% 1 Moonwalk Biosciences
9 Sequoia Capital Venture capital firm Menlo Park, United States 1 1%
10 Menlo Ventures Venture capital firm Menlo Park, United States 1 1%
11 New Enterprise Associates Venture capital firm Menlo Park, United States 1 1%
12 Invus Private equity firm New York, United States 1 1% 1 Lycia Therapeutics
13 Franklin Templeton Private equity firm San Mateo, United States 1 1% 1 Lycia Therapeutics
14 Blue Owl Private equity firm New York, United States 1 1% 1 Lycia Therapeutics
15 BlackRock Investment bank New York, United States 1 1%

Table 3. Biotech startups in South San Francisco, California: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 59 86% $9.3B
Software 12 17% $3.1B
Artificial intelligence 10 14% $2.3B
Hardware 1 1% $155.0M
Energy 1 1% $78.0M

Table 4. Biotech startups in South San Francisco, California by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Pre-seed 2 3% $500K
Seed 14 20% $6.2M
Series A 19 28% $68.0M
Series B 15 22% $73.8M
Series C 8 12% $100.0M
Series D+ 11 16% $75.0M

Table 5. Biotech startups in South San Francisco, California by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
October 2026 1 7% $215.0M
September 2026 3 21% $437.5M
June 2026 3 21% $273.8M
March 2026 2 14% $174.0M
February 2026 1 7% $13.5M
January 2026 2 14% $257.0M
December 2025 1 7% $100.0M
November 2025 1 7% $13.0M

Table 6. Biotech startups in South San Francisco, California: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 12 17% $1.4B
2025 8 12% $555.4M
2024 10 14% $1.9B
2023 5 7% $156.7M
2022 4 6% $125.4M
2021 8 12% $975.2M

Table 7. Biotech startups in South San Francisco, California by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 10 15%
2020 to 2022 12 18%
2015 to 2019 26 38%
2010 to 2014 5 7%
Before 2010 15 22%

Table 8. Biotech startups in South San Francisco, California by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 10 15%
11 to 50 35 52%
51 to 100 14 21%
101 to 250 4 6%
251 to 500 2 3%
10,001 or more 2 3%

Table 9. Biotech startups in South San Francisco, California by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in South San Francisco, California are on the list?
69, in the file dated 16 November 2026. 14 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 69 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups in South San Francisco, California: 69 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Other sectors in South San Francisco

Biotech startups elsewhere

Cite: FundingWatcher, 69 funded biotech companies in South San Francisco, California, 16 November 2026. https://fundingwatcher.com/startups/biotech/south-san-francisco-california/